scholarly journals Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study

2017 ◽  
Vol 108 (6) ◽  
pp. 1223-1230 ◽  
Author(s):  
Naoya Yamazaki ◽  
Yoshio Kiyohara ◽  
Hisashi Uhara ◽  
Jiro Uehara ◽  
Manabu Fujimoto ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase

scholarly journals Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

2010 ◽  
Vol 21 (8) ◽  
pp. 1712-1717 ◽  
Author(s):  
S.J. O'Day ◽  
M. Maio ◽  
V. Chiarion-Sileni ◽  
T.F. Gajewski ◽  
H. Pehamberger ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Melanoma ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer: A Phase II Study

2008 ◽  
Vol 3 (12) ◽  
pp. 1439-1445 ◽  
Author(s):  
Kaoru Kubota ◽  
Yutaka Nishiwaki ◽  
Tomohide Tamura ◽  
Kazuhiko Nakagawa ◽  
Kaoru Matsui ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

scholarly journals Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study

2012 ◽  
Vol 47 (12) ◽  
pp. 1342-1351 ◽  
Author(s):  
Takumi Kawaguchi ◽  
Atsumasa Komori ◽  
Masataka Seike ◽  
Shigetoshi Fujiyama ◽  
Hiroshi Watanabe ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Chronic Liver ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document